Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

Haugen CE, Holscher CM, Luo X, Bowring MG, Orandi BJ, Thomas AG, Garonzik-Wang J, Massie AB, Philosophe B, McAdams-DeMarco M, Segev DL.

JAMA Surg. 2019 Feb 13. doi: 10.1001/jamasurg.2018.5568. [Epub ahead of print]

PMID:
30758494
2.

The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial.

Henderson ML, Thomas AG, Eno AK, Waldram MM, Bannon J, Massie AB, Levan MA, Segev DL, Bingaman AW.

JMIR Res Protoc. 2019 Jan 15;8(1):e11000. doi: 10.2196/11000.

3.

Offspring living kidney donors should not be ruled out.

Holscher CM, Luo X, Massie AB, Segev DL.

Am J Transplant. 2019 Jan 17. doi: 10.1111/ajt.15264. [Epub ahead of print] No abstract available.

PMID:
30653826
4.

The landscape of international living kidney donation in the United States.

Al Ammary F, Thomas AG, Massie AB, Muzaale AD, Shaffer AA, Koons B, Qadi MA, Crews DC, Garonzik-Wang J, Fang H, Brennan DC, Lentine KL, Segev DL, Henderson ML.

Am J Transplant. 2019 Jan 7. doi: 10.1111/ajt.15256. [Epub ahead of print]

PMID:
30615253
5.

Mitochondrial membrane potential and delayed graft function following kidney transplantation.

Garonzik-Wang JM, Lonze BE, Ruck JM, Luo X, Massie AB, Melancon K, Burdick JF, Segev DL, Sun Z.

Am J Transplant. 2019 Feb;19(2):585-590. doi: 10.1111/ajt.15174. Epub 2018 Dec 4.

PMID:
30408329
6.

Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation.

Sandal S, Bae S, McAdams-DeMarco M, Massie AB, Lentine KL, Cantarovich M, Segev DL.

Am J Transplant. 2018 Oct 29. doi: 10.1111/ajt.15148. [Epub ahead of print]

PMID:
30372596
7.

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS.

Jackson KR, Covarrubias K, Holscher CM, Luo X, Chen J, Massie AB, Desai N, Brennan DC, Segev DL, Garonzik-Wang J.

Am J Transplant. 2018 Oct 29. doi: 10.1111/ajt.15149. [Epub ahead of print]

PMID:
30372592
8.

Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.

Ishaque T, Massie AB, Bowring MG, Haugen CE, Ruck JM, Halpern SE, Waldram MM, Henderson ML, Garonzik Wang JM, Cameron AM, Philosophe B, Ottmann S, Rositch AF, Segev DL.

Am J Transplant. 2019 Feb;19(2):564-572. doi: 10.1111/ajt.15144. Epub 2018 Nov 9.

PMID:
30312530
9.

Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study.

Eno AK, Thomas AG, Ruck JM, Van Pilsum Rasmussen SE, Halpern SE, Waldram MM, Muzaale AD, Purnell TS, Massie AB, Garonzik Wang JM, Lentine KL, Segev DL, Henderson ML.

JMIR Mhealth Uhealth. 2018 Oct 9;6(10):e11192. doi: 10.2196/11192.

10.

Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.

Holscher CM, Luo X, Massie AB, Purnell TS, Garonzik Wang JM, Bae S, Henderson ML, Ammary FA, Ottman SE, Segev DL.

Am J Transplant. 2019 Jan;19(1):269-276. doi: 10.1111/ajt.15126. Epub 2018 Oct 16.

PMID:
30253051
11.

Early Hypertension and Diabetes after Living Kidney Donation: A National Cohort Study.

Holscher CM, Kmd SB, Thomas AG, Henderson ML, Haugen CE, DiBrito SR, Muzaale AD, Garonzik Wang JM, Massie AB, Lentine KL, Segev DL.

Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002411. [Epub ahead of print]

PMID:
30247449
12.

Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients.

Mogul DB, Luo X, Garonzik-Wang J, Bowring MG, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL.

Liver Transpl. 2019 Jan;25(1):119-127. doi: 10.1002/lt.25340.

PMID:
30230191
13.

Anxiety, depression, and regret of donation in living kidney donors.

Holscher CM, Leanza J, Thomas AG, Waldram MM, Haugen CE, Jackson KR, Bae S, Massie AB, Segev DL.

BMC Nephrol. 2018 Sep 4;19(1):218. doi: 10.1186/s12882-018-1024-0.

14.

Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients.

Ruck JM, Jackson AM, Massie AB, Segev DL, Desai N, Garonzik-Wang J.

Transplantation. 2018 Aug 20. doi: 10.1097/TP.0000000000002426. [Epub ahead of print]

PMID:
30130329
15.

Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.

Holscher CM, Ishaque T, Garonzik Wang JM, Haugen CE, DiBrito SR, Jackson KR, Muzaale AD, Massie AB, Al Ammary F, Ottman SE, Henderson ML, Segev DL.

Am J Transplant. 2018 Nov;18(11):2804-2810. doi: 10.1111/ajt.15061. Epub 2018 Aug 31.

PMID:
30086198
16.

Temporal changes in the composition of a large multicenter kidney exchange clearinghouse: Do the hard-to-match accumulate?

Holscher CM, Jackson K, Thomas AG, Haugen CE, DiBrito SR, Covarrubias K, Gentry SE, Ronin M, Waterman AD, Massie AB, Garonzik Wang J, Segev DL.

Am J Transplant. 2018 Nov;18(11):2791-2797. doi: 10.1111/ajt.15046. Epub 2018 Sep 12.

PMID:
30063811
17.

MELD allocation system: There is always space to improve.

Luo X, Massie AB, Gentry SE, Segev DL.

Am J Transplant. 2018 Nov;18(11):2834-2835. doi: 10.1111/ajt.15036. Epub 2018 Aug 13. No abstract available.

PMID:
30052316
18.

Prospective Validation of Prediction Model for Kidney Discard.

Zhou S, Massie AB, Holscher CM, Waldram MM, Ishaque T, Thomas AG, Segev DL.

Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002362. [Epub ahead of print]

PMID:
30015701
19.

Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

Henderson ML, DiBrito SR, Thomas AG, Holscher CM, Shaffer AA, Bowring MG, Purnell TS, Massie AB, Garonzik-Wang JM, Waldram MM, Lentine KL, Segev DL.

Transplantation. 2018 Jul;102(7):1148-1155. doi: 10.1097/TP.0000000000002082.

PMID:
29952925
20.

Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Durand CM, Halpern SE, Bowring MG, Bismut GA, Kusemiju OT, Doby B, Fernandez RE, Kirby CS, Ostrander D, Stock PG, Mehta S, Turgeon NA, Wojciechowski D, Huprikar S, Florman S, Ottmann S, Desai NM, Cameron A, Massie AB, Tobian AAR, Redd AD, Segev DL.

Am J Transplant. 2018 Oct;18(10):2579-2586. doi: 10.1111/ajt.14993. Epub 2018 Jul 23.

PMID:
29947471
21.

Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.

Bae S, Massie AB, Thomas AG, Bahn G, Luo X, Jackson KR, Ottmann SE, Brennan DC, Desai NM, Coresh J, Segev DL, Garonzik Wang JM.

Am J Transplant. 2019 Feb;19(2):425-433. doi: 10.1111/ajt.14978. Epub 2018 Jul 14.

PMID:
29935051
22.

Consent and labeling in the use of infectious risk donor kidneys: A response to "Information Overload".

Bowring MG, Massie AB, Henderson M, Segev DL.

Am J Transplant. 2018 Oct;18(10):2608-2609. doi: 10.1111/ajt.14975. Epub 2018 Jul 2. No abstract available.

PMID:
29920936
23.

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.

Bowring MG, Kucirka LM, Massie AB, Ishaque T, Bae S, Shaffer AA, Garonzik Wang J, Sulkowski M, Desai N, Segev DL, Durand CM.

Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323.

PMID:
29912046
24.

Interviews of living kidney donors to assess donation-related concerns and information-gathering practices.

Ruck JM, Van Pilsum Rasmussen SE, Henderson ML, Massie AB, Segev DL.

BMC Nephrol. 2018 Jun 8;19(1):130. doi: 10.1186/s12882-018-0935-0.

25.

Racial differences in completion of the living kidney donor evaluation process.

Kumar K, Tonascia JM, Muzaale AD, Purnell TS, Ottmann SE, Al Ammary F, Bowring MG, Poon A, King EA, Massie AB, Chow EKH, Thomas AG, Ying H, Borja M, Konel JM, Henderson M, Cameron AM, Garonzik-Wang JM, Segev DL.

Clin Transplant. 2018 Jul;32(7):e13291. doi: 10.1111/ctr.13291. Epub 2018 Jun 15.

PMID:
29791039
26.

Willingness to Donate Organs Among People Living With HIV.

Nguyen AQ, Anjum SK, Halpern SE, Kumar K, Van Pilsum Rasmussen SE, Doby B, Shaffer AA, Massie AB, Tobian AAR, Segev DL, Sugarman J, Durand CM.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):e30-e36. doi: 10.1097/QAI.0000000000001760.

PMID:
29781880
27.

Kidney offer acceptance at programs undergoing a Systems Improvement Agreement.

Bowring MG, Massie AB, Craig-Schapiro R, Segev DL, Nicholas LH.

Am J Transplant. 2018 Sep;18(9):2182-2188. doi: 10.1111/ajt.14907. Epub 2018 Jun 4.

PMID:
29718565
28.

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.

Durand CM, Bowring MG, Thomas AG, Kucirka LM, Massie AB, Cameron A, Desai NM, Sulkowski M, Segev DL.

Ann Intern Med. 2018 May 15;168(10):702-711. doi: 10.7326/M17-2451. Epub 2018 Apr 17.

29.

Correlation Between Kidney Transplant Outcome Metrics and Waitlist Metrics.

Zhou S, Holscher CM, Massie AB, Segev DL, Nicholas LH.

Transplantation. 2018 Aug;102(8):e362-e363. doi: 10.1097/TP.0000000000002254. No abstract available.

PMID:
29688995
30.

Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Haugen CE, Thomas AG, Garonzik-Wang J, Massie AB, Segev DL.

Transplantation. 2018 Sep;102(9):1514-1519. doi: 10.1097/TP.0000000000002190.

PMID:
29570165
31.

Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata.

Sandal S, Luo X, Massie AB, Paraskevas S, Cantarovich M, Segev DL.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1251-1259. doi: 10.1093/ndt/gfy010.

PMID:
29474675
32.

Kidney exchange match rates in a large multicenter clearinghouse.

Holscher CM, Jackson K, Chow EKH, Thomas AG, Haugen CE, DiBrito SR, Purcell C, Ronin M, Waterman AD, Garonzik Wang J, Massie AB, Gentry SE, Segev DL.

Am J Transplant. 2018 Jun;18(6):1510-1517. doi: 10.1111/ajt.14689. Epub 2018 Mar 9.

PMID:
29437286
33.

The Authors' Reply.

Massie AB, Roberts JP.

Transplantation. 2018 May;102(5):e250-e251. doi: 10.1097/TP.0000000000002109. No abstract available.

PMID:
29346261
34.

MELD as a metric for survival benefit of liver transplantation.

Luo X, Leanza J, Massie AB, Garonzik-Wang JM, Haugen CE, Gentry SE, Ottmann SE, Segev DL.

Am J Transplant. 2018 May;18(5):1231-1237. doi: 10.1111/ajt.14660. Epub 2018 Feb 19.

PMID:
29316310
35.

Fifteen-Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts.

Mogul DB, Luo X, Bowring MG, Chow EK, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL.

J Pediatr. 2018 May;196:148-153.e2. doi: 10.1016/j.jpeds.2017.11.015. Epub 2018 Jan 4.

PMID:
29307689
36.

Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.

Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, Gordon EJ, Crews DC, Boulware LE, Segev DL.

JAMA. 2018 Jan 2;319(1):49-61. doi: 10.1001/jama.2017.19152.

37.

Electronic messaging and communication with living kidney donors.

Ruck JM, Zhou S, Thomas AG, Cramm SL, Massie AB, Montgomery JR, Berger JC, Henderson ML, Segev DL.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13184. Epub 2018 Feb 5.

38.

Geographic disparity in kidney transplantation under KAS.

Zhou S, Massie AB, Luo X, Ruck JM, Chow EKH, Bowring MG, Bae S, Segev DL, Gentry SE.

Am J Transplant. 2018 Jun;18(6):1415-1423. doi: 10.1111/ajt.14622. Epub 2018 Jan 27.

PMID:
29232040
39.

Shipping living donor kidneys and transplant recipient outcomes.

Treat E, Chow EKH, Peipert JD, Waterman A, Kwan L, Massie AB, Thomas AG, Bowring MG, Leeser D, Flechner S, Melcher ML, Kapur S, Segev DL, Veale J.

Am J Transplant. 2018 Mar;18(3):632-641. doi: 10.1111/ajt.14597. Epub 2017 Dec 18.

PMID:
29165871
40.

Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Bowring MG, Holscher CM, Zhou S, Massie AB, Garonzik-Wang J, Kucirka LM, Gentry SE, Segev DL.

Am J Transplant. 2018 Mar;18(3):617-624. doi: 10.1111/ajt.14577. Epub 2017 Dec 5.

PMID:
29116674
41.

Geographic Disparity in Liver Allocation: Time to Act or Have Others Act for Us.

Massie AB, Roberts JP.

Transplantation. 2018 Feb;102(2):189-190. doi: 10.1097/TP.0000000000001993. No abstract available.

PMID:
29095249
42.

Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States.

Luo X, Massie AB, Haugen CE, Choudhury R, Ruck JM, Shaffer AA, Zhou S, Segev DL, Garonzik-Wang JM.

Transplantation. 2018 Apr;102(4):609-615. doi: 10.1097/TP.0000000000001984.

PMID:
29077659
43.

Factors associated with perceived donation-related financial burden among living kidney donors.

Ruck JM, Holscher CM, Purnell TS, Massie AB, Henderson ML, Segev DL.

Am J Transplant. 2018 Mar;18(3):715-719. doi: 10.1111/ajt.14548. Epub 2017 Nov 21.

PMID:
29068176
44.

Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.

Mogul DB, Luo X, Chow EK, Massie AB, Purnell TS, Schwarz KB, Cameron AM, Bridges JFP, Segev DL.

J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):436-441. doi: 10.1097/MPG.0000000000001793.

PMID:
29045352
45.

Persistent regional and racial disparities in nondirected living kidney donation.

Kumar K, Holscher CM, Luo X, Garonzik Wang J, Anjum S, King EA, Massie AB, Tonascia JM, Purnell TS, Segev DL.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13135. Epub 2017 Nov 2.

46.

Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.

Chow EK, DiBrito S, Luo X, Wickliffe CE, Massie AB, Locke JE, Gentry SE, Garonzik-Wang J, Segev DL.

Transplantation. 2018 Mar;102(3):471-477. doi: 10.1097/TP.0000000000001957.

PMID:
28938312
47.

Deceased-Donor Liver Size and the Sex-Based Disparity in Liver Transplantation.

Bowring MG, Ruck JM, Haugen CE, Massie AB, Segev DL, Gentry SE.

Transplantation. 2017 Nov;101(11):e329. doi: 10.1097/TP.0000000000001898. No abstract available.

48.

The Living Donor Collective: A Scientific Registry for Living Donors.

Kasiske BL, Asrani SK, Dew MA, Henderson ML, Henrich C, Humar A, Israni AK, Lentine KL, Matas AJ, Newell KA, LaPointe Rudow D, Massie AB, Snyder JJ, Taler SJ, Trotter JF, Waterman AD; Living Donor Collective participants.

Am J Transplant. 2017 Dec;17(12):3040-3048. doi: 10.1111/ajt.14365. Epub 2017 Jun 22.

49.

The National Landscape of Living Kidney Donor Follow-Up in the United States.

Henderson ML, Thomas AG, Shaffer A, Massie AB, Luo X, Holscher CM, Purnell TS, Lentine KL, Segev DL.

Am J Transplant. 2017 Dec;17(12):3131-3140. doi: 10.1111/ajt.14356. Epub 2017 Jun 30.

50.

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.

Supplemental Content

Loading ...
Support Center